Results 41 to 50 of about 9,727 (192)
Rehabilitation needs of long COVID patients in British Columbia
Abstract Introduction COVID‐19 can result in persistent symptoms and functional impairment that significantly impact daily functioning, highlighting the need for targeted rehabilitation. However, there is a lack of data on what proportion of long COVID patients need rehabilitation and which types are required.
Débora M. Petry Moecke +6 more
wiley +1 more source
Genetics of catatonia: a systematic review of case reports and a gene pathway analysis
Background Neurodevelopmental conditions are crucial risk factors for catatonia in pediatric and adult populations. Recent case reports and studies have identified an increasing number of genetic abnormalities likely contributing to catatonia.
Mylene Moyal +4 more
doaj +1 more source
Abstract Objectives Autistic individuals are at increased risk of psychotic experiences and being diagnosed with psychotic disorders. This association may result from methodological issues, including the misinterpretation of psychosis questionnaires by autistic individuals and clinicians' difficulty distinguishing between the conditions.
Michael R. Miles +2 more
wiley +1 more source
Electroconvulsive Therapy for Patients with Catatonia: Current Perspectives
Jenifer R Lloyd,1 Eric R Silverman,1 Joseph L Kugler,2 Joseph J Cooper1 1Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA; 2Department of Psychiatry, University of Texas-Dell Medical School, Austin, TX, USACorrespondence ...
Lloyd JR +3 more
doaj
Lorazepam-Resistant Catatonia in an Antipsychotic-Naïve 24-Year-Old with Psychotic Symptoms
Catatonia is a complex identifiable clinical syndrome characterized primarily by psychomotor symptoms. In recent decades, some authors have considered that catatonia can be presented as a catatonic syndrome in several pathologies such as bipolar disorder,
Juan Pablo Lucchelli +3 more
doaj +1 more source
Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen +2 more
wiley +1 more source
Caregivers' perspectives of support needs for adolescents with fetal alcohol spectrum disorder
Abstract Research focused on fetal alcohol spectrum disorder (FASD) is often deficit‐focused, limiting a holistic understanding of individuals' support needs. Families of adolescents with FASD also struggle to access appropriate services. Using semi‐structured interviews, the current study explored the perspectives of seven caregivers of adolescents ...
Kelly Skorka +4 more
wiley +1 more source
Refractory catatonia in old age: a case report
Background Catatonia is a clinical syndrome characterized by psychomotor disruption, which often goes undiagnosed. Most reports have focused on interventions and outcomes for catatonia in younger people and those with schizophrenia.
Emma Bean +3 more
doaj +1 more source
Measuring catatonia motor behavior with objective instrumentation
ObjectiveCatatonia is a neuropsychiatric syndrome, with important psychomotor features, associated with schizophrenia and other psychiatric disorders.
Sofie von Känel +7 more
doaj +1 more source
Immune involvement in neuropsychiatric disorders: Insights from single‐cell transcriptomic studies
Neuropsychiatric disorders pose profound challenges to both research and treatment, largely due to their clinical heterogeneity and the limited understanding of their underlying biological mechanisms. While bulk RNA sequencing (bulk RNA‐seq) has been widely used to study gene expression, it cannot resolve cell‐type‐specific signals or detect rare ...
Tsutomu Takeda +4 more
wiley +1 more source

